BRIDGING THE HEALTHSPAN – LIFESPAN GAP

As lifespans have increased globally, so too have the challenges associated with maintaining health throughout those extended years. Despite advancements, HealthSpan—the period of life spent in good health—has not kept pace, primarily due to the prevalence of chronic diseases. 

Unbalanced lifestyles and the elongation of lifespan contribute to the exacerbation of age-related disorders and underlying health issues. This imbalance results in a greater burden on healthcare systems and diminished quality of life for individuals. 

Addressing this disparity requires a focus on slowing the aging process itself. By targeting the mechanisms of senescence—the biological aging process—we can simultaneously improve both morbidity (the prevalence of disease) and mortality rates worldwide. 

CONVEYXO’s MISSION

At the heart of our mission is the desire to reduce the health span-lifespan gap. To achieve this, we dedicate ourselves to a healthier elder lifespan through the development of a Anti inflamm-aging & Anti-inflammatory Technology Platform to slowdown cells aging & senescence and to cure high prevalence unmet medical needs.

Through our anti-inflammageing platform, we’ve developed an exosome-based therapeutic portfolio, leveraging Extracellular Vesicles (EVs) derived from mesenchymal stem cells. These EVs are tailored to enhance their intrinsic anti-inflammatory and regenerative properties, supplemented with loaded cargo, particularly RNA. 

OUR ANTI-INFLAMMAGEING PLATFORM & THERAPEUTIC PORTFOLIO